As SETD7 is a promising target in several diseases, including diabetes, alopecia areata, cancers and virus infection, several attempts have been made to discovery of SETD7 inhibitors12, 13, 14, 15, 16, 17, 18, 19, but the majority of these inhibitors have weak inhibitory activity. This evidence concerns the gene SETD7 and viral infectious disease.